Efficacy and Safety of Pazopanib in Patients With Metastatic Renal Cell Carcinoma Editorial Comment

被引:0
|
作者
Marshall, Fray F.
机构
来源
JOURNAL OF UROLOGY | 2010年 / 184卷 / 04期
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1303 / 1303
页数:1
相关论文
共 50 条
  • [1] Efficacy and Safety of Pazopanib in Patients With Metastatic Renal Cell Carcinoma
    Hutson, Thomas E.
    Davis, Ian D.
    Machiels, Jean-Pascal H.
    De Souza, Paul L.
    Rottey, Sylvie
    Hong, Bao-fa
    Epstein, Richard J.
    Baker, Katherine L.
    McCann, Lauren
    Crofts, Theresa
    Pandite, Lini
    Figlin, Robert A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (03) : 475 - 480
  • [2] Efficacy and safety of Pazopanib in the treatment of metastatic renal cell carcinoma
    Marmesat Rodas, B.
    Marquez Fernandez, E.
    Quesada Sanz, M. P.
    Guerra Estevez, D.
    Villanueva Jimenez, P.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (02) : 572 - 572
  • [3] To compare the efficacy and safety of pazopanib and sunitinib in metastatic renal cell carcinoma (RCC) of Chinese population
    Chan, M. F. T.
    Lam, Q. Y. N.
    Lee, V. H. F.
    Siu, S. W. K.
    Kwong, P. W. K.
    Leung, T. W.
    ANNALS OF ONCOLOGY, 2015, 26 : 77 - 77
  • [4] Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial Editorial Comment
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2011, 185 (03): : 808 - 808
  • [5] Is Pazopanib Safe and Efficacious in Patients with Metastatic Renal Cell Carcinoma?
    Ronald M. Bukowski
    Current Oncology Reports, 2010, 12 : 77 - 79
  • [6] Is Pazopanib Safe and Efficacious in Patients with Metastatic Renal Cell Carcinoma?
    Bukowski, Ronald M.
    CURRENT ONCOLOGY REPORTS, 2010, 12 (02) : 77 - 79
  • [7] Re: Efficacy and Toxicity of Sunitinib in Patients With Metastatic Renal Cell Carcinoma With Severe Renal Impairment or in Haemodialysis Editorial Comment
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2012, 187 (04): : 1223 - 1224
  • [8] Efficacy and safety of pazopanib as a subsequent treatment after failure of other targeted agents in patients with metastatic renal cell carcinoma (mRCC).
    Tan, Jiahuai
    Heilbrun, Lance K.
    Fontana, Joseph A.
    Smith, Daryn
    Heath, Elisabeth I.
    Baranowski, Karen
    Vaishampayan, Ulka N.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [9] Efficacy and safety of axitinib in elderly patients with metastatic renal cell carcinoma
    Miyake, Hideaki
    Harada, Ken-ichi
    Ozono, Seiichiro
    Fujisawa, Masato
    MEDICAL ONCOLOGY, 2016, 33 (08)
  • [10] Efficacy and safety of everolimus in Korean patients with metastatic renal cell carcinoma
    Ki Hyang Kim
    Sang Hyun Yoon
    Hae-Jung Lee
    Hyo Song Kim
    Sang Joon Shin
    Joong Bae Ahn
    Sun Young Rha
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 853 - 860